CASC3 and leukemia: Besides NFκB, the pro-survival pathways via AKT/mTOR [105–107] and insulin-like growth factor 1 (IGF-1) [108–110] have also been described to confer BTZ resistance and may affect the interaction of leukemia cells with (stromal) cells in their micro-environment.